Diagnosis and management of pulmonary embolism

December 2005
Thorax;Dec2005 Supplement 2, Vol. 60, pii51
Academic Journal
The article presents several abstracts related to the diagnosis and management of pulmonary embolism. They include "BTS Study of Three Versus Six Months' Anticoagulation for Pulmonary Venous Thromboembolism," by I.A. Campbell, "Diagnosis and Treatment of Pulmonary Embolism: Findings From the Verity VTE Treatment Registry," by N. Scrivenm, P. Rose, F. Pressley, R. Arya and D. O'Shaughnessy, and "Can the Use of BTS Pulmonary Embolism Guidelines Help in Reducing Unnecessary CT Pulmonary Angiogram Scanning?," by P.K. Sarkar, S.Kaneri, M. Farrugia and G.E. Wilson.


Related Articles

  • Meta-analysis: outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography. Moores, Lisa K.; Jackson, Jr., William L.; Shorr, Andrew F.; Jackson, Jeffrey L.; Jackson, William L Jr // Annals of Internal Medicine;12/7/2004, Vol. 141 Issue 11, p866 

    Background: Spiral computed tomographic pulmonary angiography (CTPA) is increasingly being used in the evaluation of patients with clinically suspected pulmonary embolism (PE). However, CTPA as a definitive diagnostic test may be limited by inadequate sensitivity, especially in...

  • Risk Factors for Venous Thromboembolism and Duration of Anticoagulation Therapy. Antonijević, Nebojša M.; Kanjuh, Vladimir; Živković, Ivana; Jovanović, Ljubica // Scripta Medica;May2013, Vol. 44 Issue 1, p35 

    An adequate regimen for prophylaxis of venous thromboembolism (VTE) requires indentification of reversible and irreversible risk factors. Recent data confirm that the greatest number of pulmonary emboli (PE) occur in non-surgical patients. VTE also develops in many surgical patients upon...

  • Clinical overview of venous thromboembolism. Schellack, Gustav; Modau, Tumelo; Schellack, Natalie // South African Pharmaceutical Journal;2015, Vol. 82 Issue 10, p21 

    Venous thromboembolism (VTE) encompasses two vascular conditions that are of significant importance, namely deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT is also the most common cause of PE. Medical and surgical patients, and individuals who are at increased risk of developing VTE...

  • Strategies for diagnosing pulmonary embolism.  // Patient Care;Mar2004, Vol. 38 Issue 3, p46 

    Discusses strategies for diagnosing pulmonary embolism (PE). Significance of rapid diagnosis and early treatment with anticoagulant therapy in the prevention of death associated with PE; Use of pulmonary angiography for diagnosing PE; Risk factors for venous thromboembolism.

  • Diagnostika pľúcnej tromboembólie -- úskalia CT angiografie. Olos, T.; Burša, F. // General Practitioner / Prakticky Lekar;Nov2011, Vol. 91 Issue 11, p669 

    Pulmonary embolism is the most serious clinical sign of thromboembolism. Diagnosis of pulmonary embolism represents a very complicated medicinal problem even nowadays. Clinical suspicion of pulmonary embolism needs to be confirmated by modern diagnostic tools. According to recent studies, the...

  • Pharmacists can help prevent venous thromboembolism. LoBuono, Charlotte // Drug Topics;9/15/2003, Vol. 147 Issue 18, p8 

    Highlights a report concerning deep vein thrombosis (DVT) and pulmonary embolism (PE) in the United States. Underutilization of regimens for the prevention of venous thromboembolism (VTE); Progress in clinical trials and guidelines for the prophylaxis and treatment of VTE; Difficulties in...

  • Nouveaux anticoagulants. Mise au point et enjeux en chirurgie orale. Lansonneur, C�dric; Guillou, Pauline; Hacquard, Aur�lie; Devisse, Manon; Lelievre, Julie; Le Gal, Gr�goire; Boisram�-Gastrin, Sylvie // M�decine Buccale Chirurgie Buccale;2013, Vol. 19 Issue 1, p11 

    Heparins, either unfractionated or lowmolecular- weight (UFH and LMWHs), and vitamin K antagonists (VKA) are currently the anticoagulants of choice for the prevention of postoperative venous thromboembolism (VTE) and for the treatment of acute venous and arterial thromboembolism. Heparins are...

  • 6 or 3 months of anticoagulant therapy did not differ for treatment failure in patients with DVT, PE, or both.  // Evidence Based Medicine;Oct2007, Vol. 12 Issue 5, p143 

    The article presents the author's view on the study "Anticoagulation for three versus six months in patients with deep thrombosis or pulmonary embolism, or both: randomized trial." He remarks that the study suggests a comparable efficacy with 3- and 6-moths of anticoagulant therapy, as both...

  • Pentasaccharides: a New Class of Anticoagulants in Clinical Practice. Abdel-Razeq, Hikmat // Journal of Coagulation Disorders;2010, Vol. 2 Issue 1, p1 

    Venous thromboembolism (VTE) remains a common but preventable disease. Increasing focus on simplicity and efficacy has led to the introduction of a new group of anticoagulants, the synthetic pentasaccharides, substances that specifically inhibit factor Xa activity, producing an antithrombotic...


Read the Article


Sign out of this library

Other Topics